My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.

    Majid MA, Smith VA, Easty DL, Baker AH, Newby AC.

    Br J Ophthalmol. 2002 Jan;86(1):97-101.PMID: 11801512 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells.

    Majid MA, Smith VA, Easty DL, Baker AH, Newby AC.

    FEBS Lett. 2002 Oct 9;529(2-3):281-5.PMID: 12372614 [PubMed - indexed for MEDLINE]Related articles

    3.

    Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.

    Fariss RN, Apte SS, Luthert PJ, Bird AC, Milam AH.

    Br J Ophthalmol. 1998 Nov;82(11):1329-34.PMID: 9924344 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.

    Chong NH, Alexander RA, Gin T, Bird AC, Luthert PJ.

    Invest Ophthalmol Vis Sci. 2000 Mar;41(3):898-902.PMID: 10711711 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.

    Qi JH, Ebrahem Q, Yeow K, Edwards DR, Fox PL, Anand-Apte B.

    J Biol Chem. 2002 Apr 19;277(16):13394-400. Epub 2002 Jan 30.PMID: 11821400 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.

    Langton KP, McKie N, Smith BM, Brown NJ, Barker MD.

    Hum Mol Genet. 2005 Dec 1;14(23):3579-86. Epub 2005 Oct 13.PMID: 16223891 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.

    Majid MA, Smith VA, Matthews FJ, Newby AC, Dick AD.

    Br J Ophthalmol. 2006 Oct;90(10):1310-5. Epub 2006 Jul 12.PMID: 16837541 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.

    Yeow KM, Kishnani NS, Hutton M, Hawkes SP, Murphy G, Edwards DR.

    Matrix Biol. 2002 Jan;21(1):75-88.PMID: 11827795 [PubMed - indexed for MEDLINE]Related articles

    9.

    Caspase-8-mediated apoptosis in human RPE cells.

    Yang P, Peairs JJ, Tano R, Zhang N, Tyrell J, Jaffe GJ.

    Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3341-9.PMID: 17591907 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    SOD2 protects against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration.

    Kasahara E, Lin LR, Ho YS, Reddy VN.

    Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3426-34.PMID: 16123448 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.

    Langton KP, McKie N, Curtis A, Goodship JA, Bond PM, Barker MD, Clarke M.

    J Biol Chem. 2000 Sep 1;275(35):27027-31.PMID: 10854443 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.

    Ahonen M, Baker AH, Kähäri VM.

    Cancer Res. 1998 Jun 1;58(11):2310-5.PMID: 9622064 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.

    Majid MA, Smith VA, Newby AC, Dick AD.

    Br J Ophthalmol. 2007 Aug;91(8):1073-6. Epub 2007 Mar 23.PMID: 17383996 [PubMed - indexed for MEDLINE]Related articles

    14.

    Human RPE expression of cell survival factors.

    Yang P, Wiser JL, Peairs JJ, Ebright JN, Zavodni ZJ, Bowes Rickman C, Jaffe GJ.

    Invest Ophthalmol Vis Sci. 2005 May;46(5):1755-64.PMID: 15851579 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A mouse model for Sorsby fundus dystrophy.

    Weber BH, Lin B, White K, Kohler K, Soboleva G, Herterich S, Seeliger MW, Jaissle GB, Grimm C, Reme C, Wenzel A, Asan E, Schrewe H.

    Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2732-40.PMID: 12147610 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway.

    Bond M, Murphy G, Bennett MR, Newby AC, Baker AH.

    J Biol Chem. 2002 Apr 19;277(16):13787-95. Epub 2002 Feb 4.PMID: 11827969 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations.

    Klenotic PA, Munier FL, Marmorstein LY, Anand-Apte B.

    J Biol Chem. 2004 Jul 16;279(29):30469-73. Epub 2004 Apr 28.PMID: 15123717 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells.

    Yang P, McKay BS, Allen JB, Jaffe GJ.

    Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2438-46.PMID: 15223828 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.

    Knupp C, Chong NH, Munro PM, Luthert PJ, Squire JM.

    J Struct Biol. 2002 Jan-Feb;137(1-2):31-40.PMID: 12064931 [PubMed - indexed for MEDLINE]Related articles

    20.

    TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.

    Kamei M, Hollyfield JG.

    Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2367-75.PMID: 10476804 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity